SPECTRE MEDICAL SERVICES LTD

Company Registration Number:
16148438 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 23 December 2024

End date: 31 December 2025

SPECTRE MEDICAL SERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

SPECTRE MEDICAL SERVICES LTD

Profit And Loss Account

for the Period Ended 31 December 2025

2025


£
Turnover: 1,813,391
Cost of sales: ( 1,813,391 )
Gross profit(or loss): 0
Distribution costs: ( 2,296,265 )
Administrative expenses: ( 1,000 )
Other operating income: 0
Operating profit(or loss): (2,297,265)
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: (2,297,265)
Tax: 0
Profit(or loss) for the financial year: (2,297,265)

SPECTRE MEDICAL SERVICES LTD

Balance sheet

As at 31 December 2025

Notes 2025


£
Called up share capital not paid: 0
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks: 3 500
Debtors: 4 8,496
Cash at bank and in hand: 0
Investments:   0
Total current assets: 8,996
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 8,996
Total assets less current liabilities: 8,996
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 8,996
Capital and reserves
Called up share capital: 8,996
Share premium account: 0
Other reserves: 0
Profit and loss account: 0
Total Shareholders' funds: 8,996

The notes form part of these financial statements

SPECTRE MEDICAL SERVICES LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 21 October 2026
and signed on behalf of the board by:

Name: Ben Biddle
Status: Director

The notes form part of these financial statements

SPECTRE MEDICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SPECTRE MEDICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025
    Average number of employees during the period 2

    Both are directors.

SPECTRE MEDICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Stocks

2025
£
Stocks 500
Total 500

SPECTRE MEDICAL SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Debtors

2025
£
Trade debtors 8,496
Prepayments and accrued income 0
Other debtors 0
Total 8,496
Debtors due after more than one year: 0